Sean Lavin

Sean Lavin Recent News

The MedTech Group: 2017 Top Picks And Catalysts
BTIG On Organovo: '3D Bioprinting Addresses Multiple Potential Markets With Large Opportunities'
Here's Every Sell-Side Rating Following iRhythm's IPO Quiet Period Expiration
Investors Can Find A Compelling Entry Point In NeoGenomics After Recent Weakness
BTIG Moves To Neutral On DexCom, But Says Shares Are Not Overvalued
Tactile Systems Likely To Expand Sales And Marketing Effort Says BTIG
NeoGenomics Shares Nearing Full Valuation In BTIG's View
BTIG On Exact Sciences Leak: Final Task Force Stance Could Lead To Routine Reimbursement More Quickly
Medtronic's Spine Division Continues To Lag The Market
Intuitive Surgical Shares Downgraded To Neutral At BTIG
Promising Zika Research Fuels Cerus Stock Surge
Everyone's Talking About ROLARR Heading Into Intuitive Surgical Earnings: Here's What It Means
UPDATE: BTIG Research Initiates Coverage On Histogenics On NeoCart Potential
UPDATE: BTIG Research Downgrades Abiomed As FDA Overhang Is Gone
BTIG Likes What It Saw At Intuitive Surgical Conference
UPDATE: BTIG Upgrades Intuitive Surgical
BTIG Equity Research Bullish On Lombard Medical Inc
Analysts At BTIG Confident In Endologix Following Meeting With Top Executives
BTIG Research: Thoratec 'Drops A Bomb' In Its Second Quarter Results
BTIG: Valeant Must Sweeten Allergan Bid To More Than $200/Share
UPDATE: BTIG Initiates Coverage On Masimo, Sees 31% Premium To Shares
UPDATE: BTIG Initiates Coverage On Intuitive Surgical
Wall Street Comfortable With Covidien Buy; Some See Move By Johnson & Johnson

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved